PharmaCorp Announces CFO Transition and Appointment of Andrew Hodson as Chief Financial Officer
New CFO Andrew Hodson brings to PharmaCorp more than 11 years of financial leadership, including capital markets experience and over six years leading global finance teams in high-growth and acquisition-driven businesses
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.